All tenders
75A50122C00076
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
Department of Health and Human Services · CA, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50122C00076
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
- Source
- usaspending
- Source ID
- CONT_AWD_75A50122C00076_7505_-NONE-_-NONE-
Details
- Location
- CA, United States
Description
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION. Awarded to: MAPP BIOPHARMACEUTICAL, INC. Sub-agency: Office of Assistant Secretary for Preparedness and Response Contract type: DEFINITIVE CONTRACT
Dates
- Publication
- 2022/09/28 12:00:00 AM UTC
- Closing date
- 2031/05/01 12:00:00 AM UTC
Estimated value
$110.9M USD
Classification
Normalized category
Healthcare & Medical